img

Global Hospital Infection Prevention And Control Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Hospital Infection Prevention And Control Market Research Report 2024

Hospital acquired infections are a growing issue of preventable disease burden in respect of morbidity and mortality in all countries.
According to MRAResearch’s new survey, global Hospital Infection Prevention And Control market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hospital Infection Prevention And Control market research.
Key companies engaged in the Hospital Infection Prevention And Control industry include 3M Company, Ansell Ltd., Belimed AG, Bemis Company, Inc., B. Braun Melsungen AG, Cantel Medical Corp., Cardinal Health, Inc., Covidien plc. and Crosstex International, Inc., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Hospital Infection Prevention And Control were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Hospital Infection Prevention And Control market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Hospital Infection Prevention And Control market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


3M Company
Ansell Ltd.
Belimed AG
Bemis Company, Inc.
B. Braun Melsungen AG
Cantel Medical Corp.
Cardinal Health, Inc.
Covidien plc.
Crosstex International, Inc.
Danaher Corp.
Diversey, Inc.
Getinge Group
Johnson & Johnson
Halyard Health, Inc.
Matachana Group
Medivators, Inc.
Purdue Pharma LP
Sealed Air Corp.
Semperit AG Holding
Synergy Health plc.
Terumo Corp.
Segment by Type
Infection Prevention Supplies
Infection Prevention Equipment
Infection Prevention Services

Segment by Application


Pneumonia
Urinary Tract Infection
Blood Stream Infection
Surgical Site Infection
MRSA
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Hospital Infection Prevention And Control report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital Infection Prevention And Control Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Infection Prevention Supplies
1.2.3 Infection Prevention Equipment
1.2.4 Infection Prevention Services
1.3 Market by Application
1.3.1 Global Hospital Infection Prevention And Control Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Pneumonia
1.3.3 Urinary Tract Infection
1.3.4 Blood Stream Infection
1.3.5 Surgical Site Infection
1.3.6 MRSA
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital Infection Prevention And Control Market Perspective (2018-2033)
2.2 Hospital Infection Prevention And Control Growth Trends by Region
2.2.1 Global Hospital Infection Prevention And Control Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Hospital Infection Prevention And Control Historic Market Size by Region (2018-2023)
2.2.3 Hospital Infection Prevention And Control Forecasted Market Size by Region (2024-2033)
2.3 Hospital Infection Prevention And Control Market Dynamics
2.3.1 Hospital Infection Prevention And Control Industry Trends
2.3.2 Hospital Infection Prevention And Control Market Drivers
2.3.3 Hospital Infection Prevention And Control Market Challenges
2.3.4 Hospital Infection Prevention And Control Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital Infection Prevention And Control Players by Revenue
3.1.1 Global Top Hospital Infection Prevention And Control Players by Revenue (2018-2023)
3.1.2 Global Hospital Infection Prevention And Control Revenue Market Share by Players (2018-2023)
3.2 Global Hospital Infection Prevention And Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital Infection Prevention And Control Revenue
3.4 Global Hospital Infection Prevention And Control Market Concentration Ratio
3.4.1 Global Hospital Infection Prevention And Control Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital Infection Prevention And Control Revenue in 2022
3.5 Hospital Infection Prevention And Control Key Players Head office and Area Served
3.6 Key Players Hospital Infection Prevention And Control Product Solution and Service
3.7 Date of Enter into Hospital Infection Prevention And Control Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital Infection Prevention And Control Breakdown Data by Type
4.1 Global Hospital Infection Prevention And Control Historic Market Size by Type (2018-2023)
4.2 Global Hospital Infection Prevention And Control Forecasted Market Size by Type (2024-2033)
5 Hospital Infection Prevention And Control Breakdown Data by Application
5.1 Global Hospital Infection Prevention And Control Historic Market Size by Application (2018-2023)
5.2 Global Hospital Infection Prevention And Control Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Hospital Infection Prevention And Control Market Size (2018-2033)
6.2 North America Hospital Infection Prevention And Control Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Hospital Infection Prevention And Control Market Size by Country (2018-2023)
6.4 North America Hospital Infection Prevention And Control Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hospital Infection Prevention And Control Market Size (2018-2033)
7.2 Europe Hospital Infection Prevention And Control Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Hospital Infection Prevention And Control Market Size by Country (2018-2023)
7.4 Europe Hospital Infection Prevention And Control Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital Infection Prevention And Control Market Size (2018-2033)
8.2 Asia-Pacific Hospital Infection Prevention And Control Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Hospital Infection Prevention And Control Market Size by Region (2018-2023)
8.4 Asia-Pacific Hospital Infection Prevention And Control Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hospital Infection Prevention And Control Market Size (2018-2033)
9.2 Latin America Hospital Infection Prevention And Control Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Hospital Infection Prevention And Control Market Size by Country (2018-2023)
9.4 Latin America Hospital Infection Prevention And Control Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital Infection Prevention And Control Market Size (2018-2033)
10.2 Middle East & Africa Hospital Infection Prevention And Control Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Hospital Infection Prevention And Control Market Size by Country (2018-2023)
10.4 Middle East & Africa Hospital Infection Prevention And Control Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 3M Company
11.1.1 3M Company Company Detail
11.1.2 3M Company Business Overview
11.1.3 3M Company Hospital Infection Prevention And Control Introduction
11.1.4 3M Company Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.1.5 3M Company Recent Development
11.2 Ansell Ltd.
11.2.1 Ansell Ltd. Company Detail
11.2.2 Ansell Ltd. Business Overview
11.2.3 Ansell Ltd. Hospital Infection Prevention And Control Introduction
11.2.4 Ansell Ltd. Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.2.5 Ansell Ltd. Recent Development
11.3 Belimed AG
11.3.1 Belimed AG Company Detail
11.3.2 Belimed AG Business Overview
11.3.3 Belimed AG Hospital Infection Prevention And Control Introduction
11.3.4 Belimed AG Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.3.5 Belimed AG Recent Development
11.4 Bemis Company, Inc.
11.4.1 Bemis Company, Inc. Company Detail
11.4.2 Bemis Company, Inc. Business Overview
11.4.3 Bemis Company, Inc. Hospital Infection Prevention And Control Introduction
11.4.4 Bemis Company, Inc. Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.4.5 Bemis Company, Inc. Recent Development
11.5 B. Braun Melsungen AG
11.5.1 B. Braun Melsungen AG Company Detail
11.5.2 B. Braun Melsungen AG Business Overview
11.5.3 B. Braun Melsungen AG Hospital Infection Prevention And Control Introduction
11.5.4 B. Braun Melsungen AG Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.5.5 B. Braun Melsungen AG Recent Development
11.6 Cantel Medical Corp.
11.6.1 Cantel Medical Corp. Company Detail
11.6.2 Cantel Medical Corp. Business Overview
11.6.3 Cantel Medical Corp. Hospital Infection Prevention And Control Introduction
11.6.4 Cantel Medical Corp. Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.6.5 Cantel Medical Corp. Recent Development
11.7 Cardinal Health, Inc.
11.7.1 Cardinal Health, Inc. Company Detail
11.7.2 Cardinal Health, Inc. Business Overview
11.7.3 Cardinal Health, Inc. Hospital Infection Prevention And Control Introduction
11.7.4 Cardinal Health, Inc. Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.7.5 Cardinal Health, Inc. Recent Development
11.8 Covidien plc.
11.8.1 Covidien plc. Company Detail
11.8.2 Covidien plc. Business Overview
11.8.3 Covidien plc. Hospital Infection Prevention And Control Introduction
11.8.4 Covidien plc. Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.8.5 Covidien plc. Recent Development
11.9 Crosstex International, Inc.
11.9.1 Crosstex International, Inc. Company Detail
11.9.2 Crosstex International, Inc. Business Overview
11.9.3 Crosstex International, Inc. Hospital Infection Prevention And Control Introduction
11.9.4 Crosstex International, Inc. Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.9.5 Crosstex International, Inc. Recent Development
11.10 Danaher Corp.
11.10.1 Danaher Corp. Company Detail
11.10.2 Danaher Corp. Business Overview
11.10.3 Danaher Corp. Hospital Infection Prevention And Control Introduction
11.10.4 Danaher Corp. Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.10.5 Danaher Corp. Recent Development
11.11 Diversey, Inc.
11.11.1 Diversey, Inc. Company Detail
11.11.2 Diversey, Inc. Business Overview
11.11.3 Diversey, Inc. Hospital Infection Prevention And Control Introduction
11.11.4 Diversey, Inc. Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.11.5 Diversey, Inc. Recent Development
11.12 Getinge Group
11.12.1 Getinge Group Company Detail
11.12.2 Getinge Group Business Overview
11.12.3 Getinge Group Hospital Infection Prevention And Control Introduction
11.12.4 Getinge Group Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.12.5 Getinge Group Recent Development
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Detail
11.13.2 Johnson & Johnson Business Overview
11.13.3 Johnson & Johnson Hospital Infection Prevention And Control Introduction
11.13.4 Johnson & Johnson Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.13.5 Johnson & Johnson Recent Development
11.14 Halyard Health, Inc.
11.14.1 Halyard Health, Inc. Company Detail
11.14.2 Halyard Health, Inc. Business Overview
11.14.3 Halyard Health, Inc. Hospital Infection Prevention And Control Introduction
11.14.4 Halyard Health, Inc. Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.14.5 Halyard Health, Inc. Recent Development
11.15 Matachana Group
11.15.1 Matachana Group Company Detail
11.15.2 Matachana Group Business Overview
11.15.3 Matachana Group Hospital Infection Prevention And Control Introduction
11.15.4 Matachana Group Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.15.5 Matachana Group Recent Development
11.16 Medivators, Inc.
11.16.1 Medivators, Inc. Company Detail
11.16.2 Medivators, Inc. Business Overview
11.16.3 Medivators, Inc. Hospital Infection Prevention And Control Introduction
11.16.4 Medivators, Inc. Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.16.5 Medivators, Inc. Recent Development
11.17 Purdue Pharma LP
11.17.1 Purdue Pharma LP Company Detail
11.17.2 Purdue Pharma LP Business Overview
11.17.3 Purdue Pharma LP Hospital Infection Prevention And Control Introduction
11.17.4 Purdue Pharma LP Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.17.5 Purdue Pharma LP Recent Development
11.18 Sealed Air Corp.
11.18.1 Sealed Air Corp. Company Detail
11.18.2 Sealed Air Corp. Business Overview
11.18.3 Sealed Air Corp. Hospital Infection Prevention And Control Introduction
11.18.4 Sealed Air Corp. Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.18.5 Sealed Air Corp. Recent Development
11.19 Semperit AG Holding
11.19.1 Semperit AG Holding Company Detail
11.19.2 Semperit AG Holding Business Overview
11.19.3 Semperit AG Holding Hospital Infection Prevention And Control Introduction
11.19.4 Semperit AG Holding Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.19.5 Semperit AG Holding Recent Development
11.20 Synergy Health plc.
11.20.1 Synergy Health plc. Company Detail
11.20.2 Synergy Health plc. Business Overview
11.20.3 Synergy Health plc. Hospital Infection Prevention And Control Introduction
11.20.4 Synergy Health plc. Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.20.5 Synergy Health plc. Recent Development
11.21 Terumo Corp.
11.21.1 Terumo Corp. Company Detail
11.21.2 Terumo Corp. Business Overview
11.21.3 Terumo Corp. Hospital Infection Prevention And Control Introduction
11.21.4 Terumo Corp. Revenue in Hospital Infection Prevention And Control Business (2018-2023)
11.21.5 Terumo Corp. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Hospital Infection Prevention And Control Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Infection Prevention Supplies
Table 3. Key Players of Infection Prevention Equipment
Table 4. Key Players of Infection Prevention Services
Table 5. Global Hospital Infection Prevention And Control Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Hospital Infection Prevention And Control Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Hospital Infection Prevention And Control Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Hospital Infection Prevention And Control Market Share by Region (2018-2023)
Table 9. Global Hospital Infection Prevention And Control Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Hospital Infection Prevention And Control Market Share by Region (2024-2033)
Table 11. Hospital Infection Prevention And Control Market Trends
Table 12. Hospital Infection Prevention And Control Market Drivers
Table 13. Hospital Infection Prevention And Control Market Challenges
Table 14. Hospital Infection Prevention And Control Market Restraints
Table 15. Global Hospital Infection Prevention And Control Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Hospital Infection Prevention And Control Market Share by Players (2018-2023)
Table 17. Global Top Hospital Infection Prevention And Control Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Infection Prevention And Control as of 2022)
Table 18. Ranking of Global Top Hospital Infection Prevention And Control Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Hospital Infection Prevention And Control Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hospital Infection Prevention And Control Product Solution and Service
Table 22. Date of Enter into Hospital Infection Prevention And Control Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hospital Infection Prevention And Control Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Hospital Infection Prevention And Control Revenue Market Share by Type (2018-2023)
Table 26. Global Hospital Infection Prevention And Control Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Hospital Infection Prevention And Control Revenue Market Share by Type (2024-2033)
Table 28. Global Hospital Infection Prevention And Control Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Hospital Infection Prevention And Control Revenue Market Share by Application (2018-2023)
Table 30. Global Hospital Infection Prevention And Control Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Hospital Infection Prevention And Control Revenue Market Share by Application (2024-2033)
Table 32. North America Hospital Infection Prevention And Control Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Hospital Infection Prevention And Control Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Hospital Infection Prevention And Control Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Hospital Infection Prevention And Control Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Hospital Infection Prevention And Control Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Hospital Infection Prevention And Control Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Hospital Infection Prevention And Control Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Hospital Infection Prevention And Control Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Hospital Infection Prevention And Control Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Hospital Infection Prevention And Control Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Hospital Infection Prevention And Control Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Hospital Infection Prevention And Control Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Hospital Infection Prevention And Control Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Hospital Infection Prevention And Control Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Hospital Infection Prevention And Control Market Size by Country (2024-2033) & (US$ Million)
Table 47. 3M Company Company Detail
Table 48. 3M Company Business Overview
Table 49. 3M Company Hospital Infection Prevention And Control Product
Table 50. 3M Company Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 51. 3M Company Recent Development
Table 52. Ansell Ltd. Company Detail
Table 53. Ansell Ltd. Business Overview
Table 54. Ansell Ltd. Hospital Infection Prevention And Control Product
Table 55. Ansell Ltd. Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 56. Ansell Ltd. Recent Development
Table 57. Belimed AG Company Detail
Table 58. Belimed AG Business Overview
Table 59. Belimed AG Hospital Infection Prevention And Control Product
Table 60. Belimed AG Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 61. Belimed AG Recent Development
Table 62. Bemis Company, Inc. Company Detail
Table 63. Bemis Company, Inc. Business Overview
Table 64. Bemis Company, Inc. Hospital Infection Prevention And Control Product
Table 65. Bemis Company, Inc. Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 66. Bemis Company, Inc. Recent Development
Table 67. B. Braun Melsungen AG Company Detail
Table 68. B. Braun Melsungen AG Business Overview
Table 69. B. Braun Melsungen AG Hospital Infection Prevention And Control Product
Table 70. B. Braun Melsungen AG Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 71. B. Braun Melsungen AG Recent Development
Table 72. Cantel Medical Corp. Company Detail
Table 73. Cantel Medical Corp. Business Overview
Table 74. Cantel Medical Corp. Hospital Infection Prevention And Control Product
Table 75. Cantel Medical Corp. Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 76. Cantel Medical Corp. Recent Development
Table 77. Cardinal Health, Inc. Company Detail
Table 78. Cardinal Health, Inc. Business Overview
Table 79. Cardinal Health, Inc. Hospital Infection Prevention And Control Product
Table 80. Cardinal Health, Inc. Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 81. Cardinal Health, Inc. Recent Development
Table 82. Covidien plc. Company Detail
Table 83. Covidien plc. Business Overview
Table 84. Covidien plc. Hospital Infection Prevention And Control Product
Table 85. Covidien plc. Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 86. Covidien plc. Recent Development
Table 87. Crosstex International, Inc. Company Detail
Table 88. Crosstex International, Inc. Business Overview
Table 89. Crosstex International, Inc. Hospital Infection Prevention And Control Product
Table 90. Crosstex International, Inc. Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 91. Crosstex International, Inc. Recent Development
Table 92. Danaher Corp. Company Detail
Table 93. Danaher Corp. Business Overview
Table 94. Danaher Corp. Hospital Infection Prevention And Control Product
Table 95. Danaher Corp. Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 96. Danaher Corp. Recent Development
Table 97. Diversey, Inc. Company Detail
Table 98. Diversey, Inc. Business Overview
Table 99. Diversey, Inc. Hospital Infection Prevention And Control Product
Table 100. Diversey, Inc. Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 101. Diversey, Inc. Recent Development
Table 102. Getinge Group Company Detail
Table 103. Getinge Group Business Overview
Table 104. Getinge Group Hospital Infection Prevention And Control Product
Table 105. Getinge Group Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 106. Getinge Group Recent Development
Table 107. Johnson & Johnson Company Detail
Table 108. Johnson & Johnson Business Overview
Table 109. Johnson & Johnson Hospital Infection Prevention And Control Product
Table 110. Johnson & Johnson Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 111. Johnson & Johnson Recent Development
Table 112. Halyard Health, Inc. Company Detail
Table 113. Halyard Health, Inc. Business Overview
Table 114. Halyard Health, Inc. Hospital Infection Prevention And Control Product
Table 115. Halyard Health, Inc. Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 116. Halyard Health, Inc. Recent Development
Table 117. Matachana Group Company Detail
Table 118. Matachana Group Business Overview
Table 119. Matachana Group Hospital Infection Prevention And Control Product
Table 120. Matachana Group Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 121. Matachana Group Recent Development
Table 122. Medivators, Inc. Company Detail
Table 123. Medivators, Inc. Business Overview
Table 124. Medivators, Inc. Hospital Infection Prevention And Control Product
Table 125. Medivators, Inc. Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 126. Medivators, Inc. Recent Development
Table 127. Purdue Pharma LP Company Detail
Table 128. Purdue Pharma LP Business Overview
Table 129. Purdue Pharma LP Hospital Infection Prevention And Control Product
Table 130. Purdue Pharma LP Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 131. Purdue Pharma LP Recent Development
Table 132. Sealed Air Corp. Company Detail
Table 133. Sealed Air Corp. Business Overview
Table 134. Sealed Air Corp. Hospital Infection Prevention And Control Product
Table 135. Sealed Air Corp. Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 136. Sealed Air Corp. Recent Development
Table 137. Semperit AG Holding Company Detail
Table 138. Semperit AG Holding Business Overview
Table 139. Semperit AG Holding Hospital Infection Prevention And Control Product
Table 140. Semperit AG Holding Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 141. Semperit AG Holding Recent Development
Table 142. Synergy Health plc. Company Detail
Table 143. Synergy Health plc. Business Overview
Table 144. Synergy Health plc. Hospital Infection Prevention And Control Product
Table 145. Synergy Health plc. Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 146. Synergy Health plc. Recent Development
Table 147. Terumo Corp. Company Detail
Table 148. Terumo Corp. Business Overview
Table 149. Terumo Corp. Hospital Infection Prevention And Control Product
Table 150. Terumo Corp. Revenue in Hospital Infection Prevention And Control Business (2018-2023) & (US$ Million)
Table 151. Terumo Corp. Recent Development
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital Infection Prevention And Control Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Hospital Infection Prevention And Control Market Share by Type: 2022 VS 2033
Figure 3. Infection Prevention Supplies Features
Figure 4. Infection Prevention Equipment Features
Figure 5. Infection Prevention Services Features
Figure 6. Global Hospital Infection Prevention And Control Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Hospital Infection Prevention And Control Market Share by Application: 2022 VS 2033
Figure 8. Pneumonia Case Studies
Figure 9. Urinary Tract Infection Case Studies
Figure 10. Blood Stream Infection Case Studies
Figure 11. Surgical Site Infection Case Studies
Figure 12. MRSA Case Studies
Figure 13. Hospital Infection Prevention And Control Report Years Considered
Figure 14. Global Hospital Infection Prevention And Control Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Hospital Infection Prevention And Control Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Hospital Infection Prevention And Control Market Share by Region: 2022 VS 2033
Figure 17. Global Hospital Infection Prevention And Control Market Share by Players in 2022
Figure 18. Global Top Hospital Infection Prevention And Control Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital Infection Prevention And Control as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Hospital Infection Prevention And Control Revenue in 2022
Figure 20. North America Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Hospital Infection Prevention And Control Market Share by Country (2018-2033)
Figure 22. United States Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Hospital Infection Prevention And Control Market Share by Country (2018-2033)
Figure 26. Germany Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Hospital Infection Prevention And Control Market Share by Region (2018-2033)
Figure 34. China Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Hospital Infection Prevention And Control Market Share by Country (2018-2033)
Figure 42. Mexico Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Hospital Infection Prevention And Control Market Share by Country (2018-2033)
Figure 46. Turkey Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Hospital Infection Prevention And Control Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. 3M Company Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 49. Ansell Ltd. Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 50. Belimed AG Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 51. Bemis Company, Inc. Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 52. B. Braun Melsungen AG Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 53. Cantel Medical Corp. Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 54. Cardinal Health, Inc. Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 55. Covidien plc. Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 56. Crosstex International, Inc. Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 57. Danaher Corp. Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 58. Diversey, Inc. Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 59. Getinge Group Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 60. Johnson & Johnson Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 61. Halyard Health, Inc. Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 62. Matachana Group Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 63. Medivators, Inc. Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 64. Purdue Pharma LP Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 65. Sealed Air Corp. Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 66. Semperit AG Holding Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 67. Synergy Health plc. Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 68. Terumo Corp. Revenue Growth Rate in Hospital Infection Prevention And Control Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed